What was known before {#section13-2054358120947210}
=====================

-   In an immunosuppressed patient presenting with new-onset psychosis, a broad differential diagnosis merits consideration; however, an approach to this differential diagnosis remains to be outlined in the literature.

-   When and how to modify the maintenance immunosuppressive regimen also remains a significant area of controversy and whether some of these agents can be re-introduced has never been reported.

What this adds {#section14-2054358120947210}
==============

-   A complete, reliable history, with input from collateral sources, and a systematic approach to differential diagnosis are crucial in assessing new-onset psychosis after solid organ transplantation.

-   Multi-disciplinary management of these patients is indispensable.

-   A simplified approach to consider when distinguishing between a primary psychiatric diagnosis versus tacrolimus-associated psychosis is presented

-   Tacrolimus can be successfully re-introduced in those who are diagnosed to have primary bipolar disorder.

Introduction {#section15-2054358120947210}
============

New-onset psychosis in a patient with a history of solid organ transplantation is a challenging clinical conundrum with a broad differential diagnosis. Primary and secondary psychiatric disorders and non-psychiatric and transplant-specific causes of psychosis merit consideration. These include infectious, toxic, immunological, metabolic, structural, vascular, and drug-related etiologies. Diagnosis relies on an extensive workup to establish an acute, chronic, and temporal presentation, in which the history and collateral reports play a crucial role; diagnosis often takes months to refine.

Following this, therapeutic considerations, and in particular when and how to modify the maintenance immunosuppressive regimen, remain controversial.^[@bibr1-2054358120947210][@bibr2-2054358120947210]-[@bibr3-2054358120947210]^ Calcineurin inhibitors (CNI) are known to cause neurotoxicity, and symptoms ranging from confusion, seizures, posterior reversible encephalopathy syndrome, and acute-onset psychosis have been reported.^[@bibr1-2054358120947210][@bibr2-2054358120947210][@bibr3-2054358120947210][@bibr4-2054358120947210][@bibr5-2054358120947210][@bibr6-2054358120947210][@bibr7-2054358120947210][@bibr8-2054358120947210]-[@bibr9-2054358120947210]^ Steroid-based regimens can contribute to neuropsychiatric changes, with symptoms ranging from mild affective, cognitive, or behavioral symptoms to florid psychotic episodes.^[@bibr10-2054358120947210]^ There is little guidance in the literature on how best to manage these patients.

New-onset psychosis in an immunosuppressed patient is sometimes hastily linked to CNIs, and transplant physicians often struggle to balance the risk of rejection with therapeutic considerations and recommendations from other consulting services. This report describes a case of new-onset psychosis in a young patient after kidney transplantation (KT) and aims to underscore important diagnostic considerations in the breadth and extent of relevant clinical work-up. We propose an approach to the differential diagnosis and work-up of this challenging clinical presentation and report the successful re-introduction of tacrolimus once the diagnosis of a primary psychiatric disorder was rendered.

Presenting Concerns {#section16-2054358120947210}
===================

A 23-year-old male with a history of a KT presented to the emergency room with a 1-week history of bizarre behavior, disorganized speech, and visual hallucinations. There was no history of fever, chills, headache, respiratory symptoms, nausea, vomiting, focal neurological deficits, seizures, urinary symptoms, or known sick contacts.

Clinical Findings {#section17-2054358120947210}
=================

Medical, Family, and Psychosocial History {#section18-2054358120947210}
-----------------------------------------

The patient's past medical history was notable for hypertension and X-linked Alport syndrome leading to end-stage renal disease. DNA sequencing had confirmed this diagnosis. The patient was known for a transition mutation at exon 7 of the *COL4A5* gene on chromosome X.^[@bibr11-2054358120947210]^ His grandmother, mother, and 2 aunts were known carriers, and 2 male cousins were affected by the mutation; one required a KT. Family history was otherwise notable for psychiatric disease of unknown type.

Fourteen months before presentation, the patient underwent an uncomplicated living donor KT and the graft was a mismatch at 6/6 HLA antigens. His crossmatch was negative and he received anti-thymocyte globulin and steroid induction, followed by a rapid steroid taper. Notably, there was a mismatch in Epstein-Barr virus serostatus (donor positive, recipient negative). Post-transplant, he did very well, and his creatinine stabilized around 100 μmol/L. His maintenance immunosuppression regimen was tacrolimus with a target trough of 6 to 8 ng/mL and mycophenolic acid 720 mg twice per day. Eventually, 5 mg of prednisone was added due to persistent neutropenia and inability to tolerate full dose of the anti-metabolite. He was known to be adherent to therapy, medical follow-ups and clinic visits and was high functioning from a psychosocial perspective. He lived with his brother, was entirely independent, worked full-time, and had a strong support network. There was no known history of substance abuse or illicit drug use.

Physical Examination and Diagnostic Testing {#section19-2054358120947210}
-------------------------------------------

On presentation, the patient was found to be alert, oriented to person, time, and place, but was agitated, easily distracted, and carried out repetitive movements, such as folding a blanket. He was afebrile and hemodynamically stable. His neck was supple, and there were no signs of a respiratory infection on the head and neck exam. His cardiac, respiratory, and abdominal exams were unremarkable. A neurological exam showed no deficits.

Given the acute course of his symptoms, their lack of specificity, and the high likelihood of an underlying organic etiology in the context of chronic immunosuppression, the patient's presentation was initially deemed atypical for neurodegenerative or psychiatric illness. A preliminary diagnosis of unspecified encephalopathy was made, with possible causes including infectious, inflammatory, autoimmune, metabolic, toxic, and structural etiologies. Immunosuppressant-related neurotoxicity, secondary to his tacrolimus or prednisone, was also considered.

Diagnostic Focus and Assessment {#section20-2054358120947210}
-------------------------------

A timeline of events pertaining to this case is shown in [Figure 1](#fig1-2054358120947210){ref-type="fig"}, and a complete differential diagnosis, with clinical investigations relevant to each etiology, is detailed in [Table 1](#table1-2054358120947210){ref-type="table"}. Infectious workup, toxicology screen, brain imaging, and cerebrospinal fluid analysis were all within normal limits. Immunological and autoimmune causes for the presentation were less likely. His serum tacrolimus trough was therapeutic. With input from a general consult liaison psychiatrist, the patient's psychosis was diagnosed as iatrogenic, secondary to immunosuppressive medication. The transplant team subsequently changed his CNI regimen to cyclosporine with a target 2-hr level of 400 to 600 ng/mL, and mycophenolic acid and prednisone were continued.

![Timeline of symptoms, investigations, and therapeutic decisions.\
*Note*. New presentations, diagnoses, therapies, and procedures are enclosed in boxes. Negative investigations are designated by the label "NEGATIVE." CBC = complete blood count; CMV = cytomegalovirus; CRP = C-reactive protein; CSP = cerebrospinal fluid; CT = computed tomography; DNA = deoxyribonucleic acid; EBV = Epstein-Barr virus; EEG = electroencephalogram; ESR = erythrocyte sedimentation rate; HIV = human immunodeficiency virus; HSV = herpes simplex virus; MRI = magnetic resonance imaging; PCR = polymerase chain reaction; TSH = thyroid stimulating hormone; WNV = West Nile virus.](10.1177_2054358120947210-fig1){#fig1-2054358120947210}

###### 

Differential Diagnosis of New-onset Psychosis in an Immunosuppressed Patient Post-renal Transplantation, With Targeted Clinical Investigations.

![](10.1177_2054358120947210-table1)

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Etiology                                                                                                                                                                                Targeted clinical investigations                                                                                                       Present case
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------
  *Infection, viral encephalitis*                                                                                                                                                                                                                                                                                                

   Arbovirus                                                                                                                                                                              CSF cell count + Arbovirus serology                                                                                                    No pleiocytosis, serology negative

   Cytomegalovirus                                                                                                                                                                        CSF cell count + CMV PCR                                                                                                               No pleiocytosis, PCR negative

   Enterovirus                                                                                                                                                                            CSF cell count + Enterovirus PCR                                                                                                       No pleiocytosis, PCR negative

   Epstein-Barr virus                                                                                                                                                                     CSF cell count + EBV CSF PCR                                                                                                           No pleiocytosis, PCR negative

   Hepatitis B and C                                                                                                                                                                      CSF cell count + Hepatitis serologies                                                                                                  No pleiocytosis, serology negative

   Herpes simplex virus 1/2                                                                                                                                                               CSF cell count + HSV PCR                                                                                                               No pleiocytosis, PCR negative

   Human immunodeficiency virus                                                                                                                                                           CSF cell count + HIV serology                                                                                                          No pleiocytosis, PCR negative

   Human polyoma virus                                                                                                                                                                    CSF cell count + PCR, serology, or urine cytology                                                                                      No pleiocytosis, PCR negative

   West Nile virus                                                                                                                                                                        CSF cell count + WNV serology                                                                                                          No pleiocytosis, serology negative

   Zika virus                                                                                                                                                                             CSF cell count + Zika serology or PCR                                                                                                  No pleiocytosis, PCR negative

  *Infection, bacterial encephalitis*                                                                                                                                                                                                                                                                                            

   Typical bacterial causes                                                                                                                                                               CSF cell count + CSF culture                                                                                                           No pleiocytosis, normal glucose, culture negative

   Bartonella henselae                                                                                                                                                                    CSF cell count + B. henselae serology                                                                                                  No pleiocytosis, normal glucose, serology negative

   Borrelia species (Lyme disease)                                                                                                                                                        CSF cell count + Lyme serology                                                                                                         No pleiocytosis, normal glucose, serology negative

   Rickettsia species                                                                                                                                                                     CSF cell count + Rickettsia serology                                                                                                   No pleiocytosis, normal glucose, serology negative

   Syphillis                                                                                                                                                                              CSF cell count + Syphillis serologies                                                                                                  No pleiocytosis, normal glucose, serology negative

  *Infection, parasitic and fungal encephalitis*                                                                                                                                                                                                                                                                                 

   Cryptococcus                                                                                                                                                                           CSF cell count + Cryptococcal antigen serology                                                                                         No pleiocytosis, serology negative

   Toxoplasmosis                                                                                                                                                                          CSF cell count + Toxoplasma serology                                                                                                   No pleiocytosis, serology negative

  *Infectious causes, other*                                                                                                                                                                                                                                                                                                     

   Delirium secondary to respiratory infections                                                                                                                                           Sputum analysis/culture, nasopharyngeal aspirate PCR, chest X-ray                                                                      Sputum analysis/culture negative, PCR negative, chest X-ray negative

   Delirium secondary to sepsis                                                                                                                                                           Blood cultures                                                                                                                         Blood cultures negative

   Delirium secondary to urinary infections                                                                                                                                               Urinalysis, urine culture                                                                                                              Urinalysis negative, Urine culture negative

  *Primary psychiatric disease*\                                                                                                                                                          Psychiatric evaluation + Mental status exam                                                                                            Consistent with first-episode psychosis after exclusion of organic causes
   Bipolar disorder, major depression with psychotic features, schizophrenia, schizophreniform disorder, brief psychotic disorder, schizoaffective disorder                                                                                                                                                                      

  *Neurocognitive disease*\                                                                                                                                                               Collateral history, Cognitive testing, Head CT/MRI                                                                                     Head CT and MRI negative
   Major or mild neurocognitive disorder (Alzheimer's, Lewy body, Frontotemporal, Vascular), Huntington's disease                                                                                                                                                                                                                

  *Intoxication, poisoning*                                                                                                                                                                                                                                                                                                      

   Alcohol, barbiturates, benzodiazepines, cannabinoids, hallucinogens, opioids, stimulants                                                                                               Urine toxicology screen                                                                                                                Urine toxicology screen negative

   Lead poisoning                                                                                                                                                                         Blood levels                                                                                                                           Not applicable

  *Structural and vascular*                                                                                                                                                                                                                                                                                                      

   Hypoxic-ischemic encephalopathy                                                                                                                                                        Head CT or MRI                                                                                                                         Head CT and MRI negative

   Non-convulsive seizure disorder                                                                                                                                                        EEG                                                                                                                                    EEG negative for epileptiform activity

   Post-transplant lymphoproliferative disorder                                                                                                                                           EBV PCR, LDH, Head CT/MRI                                                                                                              EBV PCR negative, LDH normal, Head CT/MRI negative

   Space-occupying lesion (tumor, cysts)                                                                                                                                                  Head CT or MRI                                                                                                                         Head CT and MRI negative

  *Medication-induced*                                                                                                                                                                                                                                                                                                           

   Tacrolimus                                                                                                                                                                             Serum tacrolimus levels, clinical assessment, diagnosis of exclusion                                                                   Levels in text; eventually undetectable

   Cyclosporine                                                                                                                                                                           Serum cyclosporine levels, clinical assessment, diagnosis of exclusion                                                                 Not applicable

   Prednisone                                                                                                                                                                             Clinical assessment, diagnosis of exclusion                                                                                            

   OKT3 monoclonal antibody-induced                                                                                                                                                       Clinical assessment, diagnosis of exclusion                                                                                            Not applicable

   Other drugs (anabolic steroids, analgesics, anticholinergics, antidepressants, antiepileptics, antimalarials, anti-parkinsonian, antivirals, cardiovascular medication, interferons)   History to determine exact medication history; work-up varies depending on drug.                                                       No known exposure to offending agents

  *Immunological and autoimmune*                                                                                                                                                                                                                                                                                                 

   Anti-NDMA receptor encephalitis                                                                                                                                                        NDMAR antibodies in CSF                                                                                                                NDMAR antibodies negative

   Encephalopathy of acute rejection                                                                                                                                                      Head CT                                                                                                                                Head CT negative

   Paraneoplastic encephalitis                                                                                                                                                            Head CT/MRI, EEG, CSF analysis for known paraneoplastic antibodies                                                                     Head imaging and EEG negative. CSF negative for known paraneoplastic antibodies

   Systemic lupus erythematosus                                                                                                                                                           Antinuclear antibodies, antiphospholipid antibodies, C3 and C4 complement levels, acute-phase reactants                                Negative for antinuclear antibodies, antiphospholipid antibodies. Normal C3 and C4 complement levels, Normal acute-phase reactants levels.

   Wilson's disease                                                                                                                                                                       CBC, liver enzymes, serum cerruloplasmin                                                                                               liver enzymes normal, serum cerruloplasmin normal

  *Endocrine/metabolic*                                                                                                                                                                                                                                                                                                          

   Adrenal disease                                                                                                                                                                        If insufficiency suspected: Morning cortisol, Plasma ACTH, Dexamethasone suppression text\                                             Morning cortisol normal
                                                                                                                                                                                          If Cushing's syndrome suspected: Late-night salivary cortisol, 24-hr urinary-free cortical excretion, Dexamethasone suppression test   

   Electrolyte abnormalities                                                                                                                                                              Serum electrolytes                                                                                                                     Serum electrolytes normal

   Hepatic encephalopathy                                                                                                                                                                 Liver enzymes                                                                                                                          Liver enzymes normal

   Parathyroid disease                                                                                                                                                                    Parathyroid hormone levels                                                                                                             Parathyroid hormone level normal

   Porphyrias (especially acute intermittent propyria)                                                                                                                                    Porphobilinogen urine test                                                                                                             Not applicable

   Thyroid disease                                                                                                                                                                        Thyroid hormone levels                                                                                                                 Thyroid hormone level normal

   Uremic encephalopathy                                                                                                                                                                  Blood urea                                                                                                                             Blood urea normal

   Vitamin B12 deficiency                                                                                                                                                                 Serum vitamin B12 level                                                                                                                Serum B12 level normal

   Wernicke encephalopathy                                                                                                                                                                Thiamine                                                                                                                               Thiamine normal
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*Note.* CBC = complete blood count; CSF = cerebrospinal fluid; CMV = cytomegalovirus; CT = computed tomography; EBV = Epstein-Barr virus; EEG = electroencephalogram; HIV = human immunodeficiency virus; HSV = herpes simplex virus; MRI = magnetic resonance imaging; PCR = polymerase chain reaction; WNV = West Nile virus.

This change did not lead to a resolution of his psychotic symptoms; rather, the patient's paranoia was exacerbated, as he became concerned his immunosuppressive therapy was poisonous. A few days later, a second psychiatric consultation with a dedicated solid-organ transplant liaison psychiatrist was obtained, and the patient's case was reassessed. Clinical interview did not reveal any subtle nor gross neurocognitive findings, only typical symptoms of mania: tangential thinking, pressure of speech, psychomotor agitation, and distractibility. This supported by extensive chart review, further collateral history, a family interview, and a detailed review of family psychiatric history led to a change in diagnosis to primary first-episode psychosis. Multiple family members were discovered to have a psychiatric illness. Of note, it emerged that the patient's behavioral changes predated his presentation by a period of several months.

Therapeutic Intervention {#section21-2054358120947210}
========================

A shared decision to start antipsychotic treatment with risperidone 0.5 mg twice daily was made with the patient, his family, and the treating teams. Only in reason of the patient' and his family's paranoia about tacrolimus, his cyclosporine was continued. The patient was initially transferred to a psychiatry ward, where he was found to tolerate the treatment and respond favorably. His symptoms improved considerably, and he was discharged with plans for outpatient follow-up with psychiatry. In the context of a history of a manic episode with psychotic features and prior depressive episodes, his diagnosis was refined to bipolar disorder type I, which was well controlled on aripiprazole, bupropion, and citalopram.

Follow-up and Outcomes {#section22-2054358120947210}
======================

About 10 months after his discharge, the patient's mental state remained stable in close follow-up with his treating psychiatrist, transplant team, and social worker. He successfully reintegrated back into the workforce, and partook in a vacation with his family. While his graft function remained stable, a protocol screen revealed a new donor-specific antibody. A for-indication allograft biopsy was done, showing glomerulitis and staining positive for C4d. A diagnosis of antibody-mediated rejection was made. Treatment included rituximab, steroids, intravenous immunoglobulins, and plasmapheresis. After careful discussion with the patient, his family, and his psychiatrist, tacrolimus was re-introduced into his maintenance regimen and cyclosporine was stopped. Six months after this change, his mental state and graft function are stable. His creatinine was at his baseline of approximately a 100 µmol/L and he has no proteinuria.

Discussion {#section23-2054358120947210}
==========

Mental health disorders are highly prevalent among those with end-stage renal disease and in those who receive transplantation. Depression affects up to 60% of solid-organ transplant recipients, and 20% develop mood and anxiety disorders within the first year after KT.^[@bibr12-2054358120947210]^ Depression is an independent risk factor for mortality in patients post KT.^[@bibr13-2054358120947210]^ Data regarding the risks of psychosis or mania in KT recipients are conflicting.^[@bibr14-2054358120947210][@bibr15-2054358120947210]-[@bibr16-2054358120947210]^ Few guidelines exist on the evaluation and management of new-onset psychiatric diseases after transplantation. Our case highlights the diagnostic challenges this presentation raises and summarizes management considerations. We propose relevant investigations for each diagnostic possibility and highlight the value of multi-disciplinary care in these patients. Most importantly, we report that tacrolimus was successfully re-introduced once the diagnosis of a primary psychiatric disorder was rendered and the patient was on a stable psychiatric regimen.

Modifying maintenance immunosuppressive regimen in KT recipients presenting with new-onset psychiatric conditions remains an area of controversy in transplant medicine. Neurotoxicity is a well-described side effect of CNIs, yet the underlying mechanism remains poorly understood. Calcineurin inhibitors may alter the intracellular environment of astrocytes, or have cytotoxic effects on brain endothelium.^[@bibr4-2054358120947210][@bibr5-2054358120947210][@bibr6-2054358120947210]-[@bibr7-2054358120947210]^ Neurotoxicity is more common with tacrolimus than with cyclosporine and is generally dose-dependent, reversible, and mild.^[@bibr4-2054358120947210],[@bibr5-2054358120947210],[@bibr17-2054358120947210]^ Presentation of CNI related psychosis is usually acute and is reported to occur within days to weeks of initiating it.^[@bibr3-2054358120947210]^ In some cases, it has been reported to occur a few months after tacrolimus use.^[@bibr1-2054358120947210],[@bibr2-2054358120947210]^ Others have reported that it can occur years after KT but was associated with trough tacrolimus blood concentrations that were higher than normal for the patient.^[@bibr8-2054358120947210],[@bibr18-2054358120947210],[@bibr19-2054358120947210]^

In patients with suspicion of CNI-induced psychosis, several approaches have been suggested to manage immunosuppression. When associated with an elevated trough level (\>10 ng/mL), some report decreasing serum levels can resolve symptoms of psychosis.^[@bibr3-2054358120947210],[@bibr18-2054358120947210],[@bibr19-2054358120947210]^ However, psychosis even at lower levels has been reported and discontinuing tacrolimus and switching to cyclosporine, everolimus, or sirolimus was reported to lead to resolution of symptoms.^[@bibr1-2054358120947210],[@bibr2-2054358120947210],[@bibr8-2054358120947210],[@bibr19-2054358120947210]^ In most cases, after the CNI is decreased or switched to another agent, resolution of psychiatric symptoms occurs within days to weeks, and in some cases, clinicians were able to completely taper off the anti-psychiatric medications.^[@bibr1-2054358120947210][@bibr2-2054358120947210]-[@bibr3-2054358120947210]^,^[@bibr8-2054358120947210],[@bibr18-2054358120947210],[@bibr19-2054358120947210]^

Tacrolimus, however, is the cornerstone of maintenance immunosuppression and one has to balance out the risks of acute rejection. As with our patient's case, others have reported a higher risk of acute rejection with tacrolimus cessation.^[@bibr1-2054358120947210]^ In one case, a patient developed 2 discrete episodes of psychosis, both of which occurred while on treatment with tacrolimus with a target trough of 3 to 8 ng/mL, with complete recovery of her mental state between episodes when tacrolimus therapy was withdrawn.^[@bibr1-2054358120947210]^ The authors tried to re-introduce tacrolimus following an episode of acute rejection but the patient presented with a psychotic episode necessitating the use of everolimus instead. In another case, a young patient presented with 2 different episodes of manic and psychotic symptoms both in the presence of elevated tacrolimus levels.^[@bibr19-2054358120947210]^ Tacrolimus was stopped and cyclosporine started but the authors do not allude into the details of why this switch was made rather than targeting a lower target trough.

We report the successful re-introduction of tacrolimus after the episode of acute rejection, as the cause of our patient's presentation was not due to the CNI. The broad range of symptoms and time courses with which CNI-related neurotoxicity can present makes it difficult to distinguish from other causes. Primary psychoses, the top differential diagnosis in this case, generally presents more insidiously, and patients exhibit distractibility, usually without neurocognitive symptoms. We present a simple approach that may guide a clinician in distinguishing between these 2 diagnoses ([Table 2](#table2-2054358120947210){ref-type="table"}). We underscore the value of drawing these distinctions in a complete history with collateral information. While a high index of suspicion of CNI-related neurotoxicity is needed, the possibility of this adverse reaction should not limit the work-up undertaken or overshadow other diagnoses on the differential as highlighted in [Table 1](#table1-2054358120947210){ref-type="table"}. An immunosuppressed patient post-KT has an increased risk of infection, cardiovascular disease, malignancy, and psychiatric disease. Consequently, a systematic assessment of changes in their mental status, including a full history and possible involvement of a specialized psychiatrist, is indispensable. Findings from a thorough clinical history and specialized psychiatric assessment will guide clinical reasoning, allowing for important distinctions between primary and secondary causes of psychosis, transplant-specific and other causes, as well as acute, subacute, and chronic presentations, which can aid in narrowing the differential diagnosis.

###### 

A Simplified Approach to Consider When Distinguishing Between a Primary Psychiatric Disorder and Tacrolimus-Associated Psychosis.

![](10.1177_2054358120947210-table2)

                                                         Primary psychiatric disorder                     Tacrolimus-associated psychosis
  ------------------------------------------------------ ------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------
  Onset                                                  Variable and usually an insidious presentation   Usually within days to weeks but years later has been reported with trough levels higher than normal for the patient
  Tacrolimus trough                                      Within normal range                              Higher or higher than normal for the patient
  Resolution of symptoms after tacrolimus discontinued   No resolution                                    Within days to weeks
  Re-introduction of tacrolimus                          No change in clinical condition                  Associated with recurrence of symptoms

In conclusions, the present report offers learners an extensive and organized differential diagnosis and a diagnostic approach to patients with a history of solid organ transplantation presenting with new-onset psychosis. Also, this is the first case report describing the successful re-introduction of tacrolimus in an immunosuppressed patient who presented with a primary psychiatric disorder.
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